European Medicines Agency Starts Valuation of Richter's Teriparatide - (Morningstar via NewsPoints Desk)

  • The European Medicines Agency accepted Gedeon Richter's marketing submission for a proposed biosimilar version of Eli Lilly's osteoporosis therapy Forteo (teriparatide), as reported Monday in Morningstar.
  • The biosimilar has been developed by Richter-Helm BioTec, and under a license agreements, the product is expected to be launched under both Richter and STADA labels in Europe.
  • Gedeon Richter is seeking approval for the same indications as Forteo.

To read more NewsPoints articles, click here.